当前位置:首页 - 行情中心 - 博瑞医药(688166) - 财务分析 - 现金流量表

博瑞医药

(688166)

  

流通市值:267.95亿  总市值:267.95亿
流通股本:4.30亿   总股本:4.30亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金223,828,389.471,170,190,718.44765,591,648.78520,621,567.05
  收到的税费返还13,707,913.244,379,598.2735,253,379.7730,178,607.03
  收到其他与经营活动有关的现金10,478,024.5639,513,792.6721,332,885.3911,591,785.52
  经营活动现金流入小计248,014,327.231,254,084,109.38822,177,913.94562,391,959.6
  购买商品、接受劳务支付的现金97,317,712.87268,726,107.01200,576,314.96115,408,176.12
  支付给职工以及为职工支付的现金72,003,923.1283,523,456.42215,274,981.42153,579,704.21
  支付的各项税费33,726,698.3663,204,256.2947,379,464.9534,678,294.58
  支付其他与经营活动有关的现金156,230,685.17313,439,478.15259,992,290.8145,113,003.68
  经营活动现金流出小计359,279,019.5928,893,297.87723,223,052.13448,779,178.59
  经营活动产生的现金流量净额-111,264,692.27325,190,811.5198,954,861.81113,612,781.01
二、投资活动产生的现金流量:
  收回投资收到的现金-53,955,10046,705,10046,705,100
  处置固定资产、无形资产和其他长期资产收回的现金净额039,791.7119,194.4217,664.42
  处置子公司及其他营业单位收到的现金净额15,000,000---
  收到的其他与投资活动有关的现金-36,813,484.16--
  投资活动现金流入小计15,000,00090,808,375.8746,724,294.4246,722,764.42
  购建固定资产、无形资产和其他长期资产支付的现金47,521,206.67453,408,729.1363,386,304.78327,294,945.44
  投资支付的现金113,194,419.26259,944,195235,907,061.74106,730,462.88
  投资活动现金流出小计160,715,625.93713,352,924.1599,293,366.52434,025,408.32
  投资活动产生的现金流量净额-145,715,625.93-622,544,548.23-552,569,072.1-387,302,643.9
三、筹资活动产生的现金流量:
  吸收投资收到的现金51,800,000399,800,000181,800,000181,800,000
  其中:子公司吸收少数股东投资收到的现金51,800,000399,800,000181,800,000181,800,000
  取得借款收到的现金1,156,739,613.92895,048,100.82613,202,925.81496,899,300
  收到其他与筹资活动有关的现金0245,000,000170,000,00070,000,000
  筹资活动现金流入小计1,208,539,613.921,539,848,100.82965,002,925.81748,699,300
  偿还债务支付的现金492,688,837.58849,545,130.01549,850,506.34409,263,943.65
  分配股利、利润或偿付利息支付的现金15,806,785.52117,602,905.2892,923,459.8580,139,714.61
  支付其他与筹资活动有关的现金8,951,785.5675,047,583.3128,563,030.7415,184,502
  筹资活动现金流出小计517,447,408.661,042,195,618.6671,336,996.93504,588,160.26
  筹资活动产生的现金流量净额691,092,205.26497,652,482.22293,665,928.88244,111,139.74
四、汇率变动对现金及现金等价物的影响-2,267,044.22662,598.026,062,765.146,309,982.47
五、现金及现金等价物净增加额431,844,842.84200,961,343.52-153,885,516.27-23,268,740.68
  加:期初现金及现金等价物余额925,555,174.04754,101,930.95754,101,930.95754,101,930.95
  期末现金及现金等价物余额1,357,400,016.88955,063,274.47600,216,414.68730,833,190.27
补充资料:
  净利润-36,954,239.18-1,657,076.47
  资产减值准备-17,497,638.54-2,766,161.91
  固定资产和投资性房地产折旧-139,258,006.16-68,653,413.53
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-139,258,006.16-68,653,413.53
  无形资产摊销-5,899,609.49-2,991,127.05
  长期待摊费用摊销-11,032,730.85-6,014,313.45
  处置固定资产、无形资产和其他长期资产的损失-0--
  固定资产报废损失-495,918.44-208,240.64
  公允价值变动损失--13,784,762.71--1,585,851.81
  财务费用-61,995,963.86-22,569,997.3
  投资损失-19,321,426.73-5,427,848.31
  递延所得税--31,936,944.27--8,009,207.93
  其中:递延所得税资产减少--31,936,944.27--8,009,207.93
    递延所得税负债增加-0--
  存货的减少--5,959,032.89--10,571,118.75
  经营性应收项目的减少-36,529,696.25-61,037,558.21
  经营性应付项目的增加-1,790,481.75--46,429,041.47
  现金的期末余额-955,063,274.47-730,833,190.27
  减:现金的期初余额-754,101,930.95-754,101,930.95
  现金及现金等价物的净增加额-200,961,343.52--23,268,740.68
公告日期2026-04-302026-03-202025-10-312025-08-29
审计意见(境内)标准无保留意见
TOP↑